EUVIMEDEUVIMED entdecken
Crossref

Giant juvenile fibroadenomas with and without prominent pseudoangiomatous stromal hyperplasia ( PASH )‐like change: clinicopathological and molecular characteristics

Julie M Jorns iD, Ayesha Farooq, Andrii Puzyrenko, Jason Jarzembowski, Aye Aye Thike, Nur Diyana Md Nasir, Cedric Chuan Young Ng, Wei Liu, Jing Yi Lee, Abner Herbert Lim, Peiyong Guan, Bin Tean Teh und 1 weitere

Histopathology · 2023

DOI: 10.1111/his.14935 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, 2023. Verfasst von Julie M Jorns und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Medical College of Wisconsin, Milwaukee, WI, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoplasms, Fibroepithelial, Breast Diseases, Fibroadenoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: MCW Department of Pathology and a SingHealth Duke-NUS Pathology Academic Clinical Programme - ACP Pathology Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Juvenile fibroadenomas (JFA) are biphasic fibroepithelial lesions (FEL) usually occurring in adolescent female patients. Giant (G) JFA, like other FEL, may exhibit prominent pseudoangiomatous stromal hyperplasia (PASH)‐like change. We sought to determine clinicopathological and molecular characteristics of GJFA with and without PASH. Methods and results Archives were searched for cases of GJFA (1985–2020). All were stained for androgen receptor (AR), beta‐catenin, CD34 and progesterone receptor (PR). Cases were sequenced using a custom 16‐gene panel – MED12 (exons 1 and 2), TERT promoter (–124C>T and –146Ctable>T), SETD2 , KMT2D , RARA (exons 5–9), FLNA , NF1 , PIK3CA (exons 10, 11 and 21), EGFR , RB1 , BCOR , TP53 , PTEN , ERBB4 , IGF1R and MAP3K1 . Twenty‐seven GJFA from 21 female patients aged 10.1–25.2 years were identified. Size ranged from 5.2 to 21 cm. Two patients had multiple, bilateral and later recurrent GJFA. Thirteen (48%) cases showed prominent PASH‐like stroma. All were positive for stromal CD34, negative for AR and beta‐catenin and one case showed focal PR expression. Sequencing showed MAP3K1 and SETD2 mutations in 17 samples, with KMT2D , TP53 and BCOR aberrations in 10 (45%), 10 (45%) and seven (32%) cases, respectively. Tumours with a PASH‐like pattern had higher prevalence of SETD2 ( P = 0.004) and TP53 ( P = 0.029) mutations, while those without PASH had more RB1 mutations ( P = 0.043). MED12 mutation was identified in one case. TERT promoter mutation was observed in four (18%), including two recurrences.

Conclusions

Gene mutations along more advanced phases of the proposed FEL pathogenetic pathway in GJFA are unusual, and suggest a mechanism for more aggressive growth in these tumours.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsNeoplasms, FibroepithelialBreast DiseasesFibroadenomaFibromaAngiomatosisAdolescentbeta CateninHyperplasiaFemaleHumans

Stichwörter der Autor:innen

PASHbreastfibroadenomafibroepithelialgiant juvenile fibroadenomanext generation sequencingpseudoangiomatous stromal hyperplasia

Substanzen

beta Catenin

Autor:innen und Institutionen

  • Department of Pathology, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Department of Pathology, Children's Hospital of Wisconsin, Madison, WI, USA.
  • Department of Anatomical Pathology, Singapore General Hospital, Singapore.
  • Laboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore.
  • Quantitative Biology and Medicine Programme, Duke-NUS Medical School, Singapore.
  • Luma Medical Centre, Singapore.

ORCID-Profile: Julie M Jorns

Förderung

  • MCW Department of Pathology and a SingHealth Duke-NUS Pathology Academic Clinical Programme - ACP Pathology Fund

Zitieren

APA

Jorns, J. M., Farooq, A., Puzyrenko, A., Jarzembowski, J., Thike, A. A., Nasir, N. D. M., Ng, C. C. Y., Liu, W., Lee, J. Y., Lim, A. H., Guan, P., Teh, B. T., & Tan, P. H. (2023). Giant juvenile fibroadenomas with and without prominent pseudoangiomatous stromal hyperplasia ( PASH )‐like change: clinicopathological and molecular characteristics. Histopathology. https://doi.org/10.1111/his.14935

Vancouver

Jorns JM, Farooq A, Puzyrenko A, Jarzembowski J, Thike AA, Nasir NDM, et al. Giant juvenile fibroadenomas with and without prominent pseudoangiomatous stromal hyperplasia ( PASH )‐like change: clinicopathological and molecular characteristics. Histopathology. 2023. doi:10.1111/his.14935

BibTeX
@article{Jorns2023,
  author = {Jorns, Julie M and Farooq, Ayesha and Puzyrenko, Andrii and Jarzembowski, Jason and Thike, Aye Aye and Nasir, Nur Diyana Md and Ng, Cedric Chuan Young and Liu, Wei and Lee, Jing Yi and Lim, Abner Herbert and Guan, Peiyong and Teh, Bin Tean and Tan, Puay Hoon},
  title = {Giant juvenile fibroadenomas with and without prominent pseudoangiomatous stromal hyperplasia ( PASH )‐like change: clinicopathological and molecular characteristics},
  journal = {Histopathology},
  year = {2023},
  doi = {10.1111/his.14935}
}
Kostenlos starten →